معرفی
John Hayward is a Researcher in the Department of Chemistry at the University of Windsor's Faculty of Science. His work spans synthetic chemistry, drug design, and cancer research, with a focus on prostate cancer diagnostics and therapies. Notably, he contributed to the development of imaging agents and anti-cancer vaccines, leveraging techniques like fluorescent probes and boron neutron capture therapy. He also participated in interdisciplinary efforts to enhance lab safety and equity initiatives, earning recognition as an EDI Awards Celebration honoree in 2024.
Research interests include the synthesis of bioactive compounds, such as psychedelics and cancer-targeting agents, alongside advancements in materials science and diagnostic tools. His collaborations with industry and academic partners highlight his commitment to bridging laboratory innovation with real-world applications.
- EDI Contributions: Honored for promoting equity, diversity, and inclusion on campus.
- Key Technologies: Developed hand sanitizer formulas during the pandemic, advancing practical solutions to public health challenges.
